紅星美凱龍(01528.HK)控股股東質押7,400萬股A股 另有1,290萬股解除質押
紅星美凱龍(01528.HK)(601828.SH)公布,公司於今年11月2日收到控股股東紅星控股通知,紅星控股已將其持有的7,400萬股有限售條件流通A股,質押給中國華融資產管理股份上海自貿試驗區分公司,佔其所持股份比例2.71%,佔公司總股本1.9%。
另外,紅星控股於2018年9月26日將持有的3.82億股公司有限售條件流通A股質押給中國銀河證券股份,用於辦理股票質押式回購交易業務。現已將其中1,290萬股股份解除了質押,佔其所持股份比例0.47%,佔公司總股本0.33%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.